Daniel Wildman

Daniel Wildman

Director/Board Member at UROGEN PHARMA LTD.

Net worth: - $ as of 30/03/2024

68 year
Health Technology
Consumer Services
Health Services

Profile

Daniel G.
Wildman
is currently the President & Chief Executive Officer at Wildman Ventures LLC, Chairman at Progenerative Medical, Inc., Director at UroGen Pharma Ltd., and Independent Non-Executive Director at Nyxoah SA. Previously, he served as an Independent Director at Precision Healing, Inc. from 2020 to 2022.
He also held positions at Johnson & Johnson, where he was the Head-Digital Surgery Strategy Initiative, and at Ethicon, Inc., where he served as the President-Ethicon Biosurgery from 2003 to 2015.
Mr. Wildman completed his undergraduate degree at St. Lawrence University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/09/2023 0 ( -.--% ) - $ 30/03/2024

Daniel Wildman active positions

CompaniesPositionStart
UROGEN PHARMA LTD. Director/Board Member 07/11/2022
NYXOAH SA Director/Board Member 07/01/2023
Chairman 28/02/2022
Wildman Ventures LLC Chief Executive Officer 31/12/2018
All active positions of Daniel Wildman

Former positions of Daniel Wildman

CompaniesPositionEnd
Director/Board Member 31/03/2022
Corporate Officer/Principal 31/12/2014
JOHNSON & JOHNSON Corporate Officer/Principal -
See the detail of Daniel Wildman's experience

Training of Daniel Wildman

St. Lawrence University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Wildman's experience

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
JOHNSON & JOHNSON

Health Technology

UROGEN PHARMA LTD.

Health Technology

NYXOAH SA

Health Technology

Private companies4

Health Technology

Health Services

Health Technology

Wildman Ventures LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Daniel Wildman